de Zeeuw D - Search Results

1

Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system?

Gansevoort RT, de Zeeuw D, de Jong PE. Gansevoort RT, et al. Among authors: de jong pe, de zeeuw d. Kidney Int. 1994 Mar;45(3):861-7. doi: 10.1038/ki.1994.113. Kidney Int. 1994. PMID: 8196289 Clinical Trial.

2

[Effect of protein restriction on deterioration of kidney function].

Gansevoort RT, de Zeeuw D, de Jong PE. Gansevoort RT, et al. Among authors: de jong pe, de zeeuw d. Ned Tijdschr Geneeskd. 1997 Nov 1;141(44):2106-10. Ned Tijdschr Geneeskd. 1997. PMID: 9550772 Review. Dutch.

3

Antiproteinuric effect of naproxen and indomethacin. A double-blind crossover study.

Vriesendorp R, Donker AJ, de Zeeuw D, de Jong PE, van der Hem GK. Vriesendorp R, et al. Among authors: de jong pe, de zeeuw d. Am J Nephrol. 1985;5(4):236-42. doi: 10.1159/000166941. Am J Nephrol. 1985. PMID: 3901756 Clinical Trial.

4

Antiproteinuric effect of ACE inhibitors.

Heeg JE, de Zeeuw D, de Jong PE. Heeg JE, et al. Among authors: de jong pe, de zeeuw d. Lancet. 1988 Nov 26;2(8622):1251-2. doi: 10.1016/s0140-6736(88)90843-4. Lancet. 1988. PMID: 2903981 No abstract available.

5

Atrial natriuretic factor: its (patho)physiological significance in humans.

de Zeeuw D, Janssen WM, de Jong PE. de Zeeuw D, et al. Among authors: de jong pe. Kidney Int. 1992 May;41(5):1115-33. doi: 10.1038/ki.1992.172. Kidney Int. 1992. PMID: 1319517

6

Atrial natriuretic factor influences renal diurnal rhythm in essential hypertension.

Janssen WM, de Zeeuw D, van der Hem GK, de Jong PE. Janssen WM, et al. Among authors: de jong pe, de zeeuw d. Hypertension. 1992 Jul;20(1):80-4. doi: 10.1161/01.hyp.20.1.80. Hypertension. 1992. PMID: 1535613

7

Noninvasive measurement of intrarenal blood flow distribution: kinetic model of renal 123I-hippuran handling.

Janssen WM, Beekhuis H, de Bruin R, de Jong PE, de Zeeuw D. Janssen WM, et al. Among authors: de jong pe, de zeeuw d, de bruin r. Am J Physiol. 1995 Oct;269(4 Pt 2):F571-80. doi: 10.1152/ajprenal.1995.269.4.F571. Am J Physiol. 1995. PMID: 7485544

8

The mechanism and diagnostic value of angiotensin I converting enzyme inhibition renography.

de Zeeuw D, Jonker GJ, Hovinga TK, Beekhuis H, Piers DA, Huisman RM, de Jong PE. de Zeeuw D, et al. Among authors: de jong pe. Am J Hypertens. 1991 Dec;4(12 Pt 2):741S-744S. doi: 10.1093/ajh/4.12.741s. Am J Hypertens. 1991. PMID: 1777188

9

A Prospective Cohort Study in Patients with Type 2 Diabetes Mellitus for Validation of Biomarkers (PROVALID) - Study Design and Baseline Characteristics.

Eder S, Leierer J, Kerschbaum J, Rosivall L, Wiecek A, de Zeeuw D, Mark PB, Heinze G, Rossing P, Heerspink HL, Mayer G. Eder S, et al. Among authors: de zeeuw d. Kidney Blood Press Res. 2018;43(1):181-190. doi: 10.1159/000487500. Epub 2018 Feb 16. Kidney Blood Press Res. 2018. PMID: 29466797

10

Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study-Renal (CANVAS-R): A randomized, placebo-controlled trial.

Neal B, Perkovic V, Matthews DR, Mahaffey KW, Fulcher G, Meininger G, Erondu N, Desai M, Shaw W, Vercruysse F, Yee J, Deng H, de Zeeuw D; CANVAS-R Trial Collaborative Group. Neal B, et al. Among authors: de zeeuw d. Diabetes Obes Metab. 2017 Mar;19(3):387-393. doi: 10.1111/dom.12829. Epub 2017 Jan 25. Diabetes Obes Metab. 2017. PMID: 28120497 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results